Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2009-013656-77-FR
EUCTR2009-013656-77-FR
Active, not recruiting
Not Applicable

Traitment of recessive nonbullous congenital ichthyosis with topic Epigallocatechin.

ice University Hospital0 sites0 target enrollmentAugust 6, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsRecessive nonbullous congenital ichthyosisMedDRA version: 12.0Level: HLTClassification code 10021197Term: Ichthyoses
DrugsVEREGEN(R)

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Recessive nonbullous congenital ichthyosis
Sponsor
ice University Hospital
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 6, 2009
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
ice University Hospital

Eligibility Criteria

Inclusion Criteria

  • •\- Both male and female patients over 8 years of age and under 64 years of age,
  • •\- Patients with diagnostic of lamellar ichthyosis,
  • •\- Patients with roughness and desquamation skin scores with moderate or severe intensity (equal or over 2 on each side of the body),
  • •\- Patients and/or parents /representatives of the parental authority able to understand and follow the proceedings of the study,
  • •\- Patients and/or parents /representatives of the parental authority willing to sign the proper consent forms,
  • •\- Patients covered by Social Security .
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range

Exclusion Criteria

  • •\- Patients under 8 years of age,
  • •\- Pregnant or breastfeeding women (a qualitative urine pregnancy test will be given to all women of child\-bearing age),
  • •\- Patients with a transaminase rate over twice the normal,
  • •\- Patients with congenital ichthyosis other than lamellar ichthyosis,
  • •\- Patients with an erythrodermic constituent,
  • •\- Patients with light roughness and desquamation skin scores (under 2 on one side of the body at least ),
  • •\- Patients with secondary infection caused by a lesion
  • •\- Patients with an allergy in one of the component of the trial product
  • •\- Patients treated with specific topics (vitamin A and D analogous for example),
  • •\- Patients treated with keratolytic (urea for example) in the 7 day before the beginning of the clinical trial,

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Phase 3
Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine CutaneousLamellar Ichthyosis
NCT01222000Centre Hospitalier Universitaire de Nice8
Recruiting
Phase 2
Treatment of congenital vascular malformations using Sirolimus: improving quality of Life
NL-OMON45838Radboud Universitair Medisch Centrum75
Active, not recruiting
Phase 1
Treatment of congenital vascular malformations with Sirolimuscongenital vascular malformation : Vascular malformationscan involve lymphatic vessels, capillaries, veins and arteries or even combinations. These vascularmalformations are present at birth and grow with the child.MedDRA version: 20.0Level: HLTClassification code 10047091Term: Vascular malformations and acquired anomaliesSystem Organ Class: 100000005125MedDRA version: 20.0Level: LLTClassification code 10047090Term: Vascular malformation peripheralSystem Organ Class: 100000158692MedDRA version: 20.0Level: PTClassification code 10070181Term: Gastrointestinal vascular malformationSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 20.0Level: PTClassification code 10074979Term: Vascular malformationSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2016-002157-38-NLRadboud University Medical Center75
Recruiting
Not Applicable
Prospective study on the treatment of congenital vaginal agenesis or vaginal hypoplasia - genital reconstruction, gynecological and urological aspects, psychosexual and social aspects and quality of lifeDisorders of sex developmenthermaphroditismintersex100386081001061210029903
NL-OMON36303Erasmus MC, Universitair Medisch Centrum Rotterdam545
Not yet recruiting
Not Applicable
International, multi-centre study on comparing management and outcomes of children born with congenital diseases between Low-­, Middle-­ and Highâ??Income Countries.
CTRI/2018/09/015833aomi Wright